Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria

Emily C Edmonds1, Joel Eppig2, Mark W Bondi2

  • 1From the Department of Psychiatry (E.C.E., M.W.B., K.M.L., B.G., L.D.-W., C.R.M.), School of Medicine, University of California San Diego, La Jolla; Joint Doctoral Program in Clinical Psychology (J.E.), San Diego State University/University of California San Diego; and Veterans Affairs San Diego Healthcare System (M.W.B., L.D.-W.), CA. ecedmonds@ucsd.edu.

Neurology
|October 21, 2016
PubMed
Abstract

Insights

Mild cognitive impairment (MCI) subtypes show distinct patterns of brain atrophy that correlate with cognitive decline. Current diagnostic criteria may lead to false positives, suggesting a need for improved subgrouping for better staging and prognosis.

Area of Science:

  • Neuroimaging
  • Neurology
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
  • Existing diagnostic criteria for MCI may not fully capture the heterogeneity of the condition.
  • Empirically derived MCI subtypes have been identified, but their neurobiological underpinnings require further investigation.

Purpose of the Study:

  • To investigate regional cortical thickness differences among empirically derived mild cognitive impairment (MCI) subtypes.
  • To determine if distinct MCI subtypes exhibit unique patterns of cortical atrophy.
  • To assess the validity of current MCI diagnostic criteria and explore potential improvements.

Main Methods:

  • Analysis of cortical thickness in 32 regions per hemisphere from 485 individuals with MCI and 178 cognitively normal controls.
  • Utilized data from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
  • Employed statistical group maps to compare cortical thickness between MCI subtypes and cognitively normal participants.

Main Results:

  • Each MCI subtype displayed a pattern of cortical thinning that aligned with its specific cognitive profile.
  • No significant cortical thickness differences were observed between the cluster-derived normal MCI subtype and cognitively normal individuals.
  • Direct comparisons between MCI subtypes indicated that cortical thinning patterns reflect increasing severity of cognitive dysfunction.

Conclusions:

  • An ordered pattern of cortical atrophy exists in MCI patients, correlating with progressive cognitive dysfunction.
  • Conventional diagnostic criteria for MCI may overlook important heterogeneity and are susceptible to false-positive errors.
  • Refining MCI diagnostic criteria and subgrouping patients based on cognitive and biomarker profiles are crucial for accurate staging and prognosis.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
656
Association Areas of the Cortex01:21

Association Areas of the Cortex

Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
10.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K